meta http-equiv="Refresh" content="0; url='https://www.biorxiv.org/content/10.1101/2021.05.01.442279v1.abstract'" /
Contact Us
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Signaling through FcgRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19

Picture of Fluxion Biosciences Fluxion Biosciences May 3, 2021 1:31:00 PM

COVID-19 Platelets Thrombosis Article Biofilm Cellular Analysis

ACCESS TO ARTICLE →